PerkinElmer has launched the EnVision Nexus system, its fastest and most sensitive multimode plate reader to date, designed for demanding high-throughput screening (HTS) applications and to accelerate drug discovery efforts. The EnVision Nexus platform, with complementary microplates and optimized reagents from PerkinElmer’s drug discovery reagents portfolio, including proprietary HTRF and AlphaLISA technologies and latest reagent kits, provides researchers increased assay flexibility.

The EnVision Nexus system features highthroughput, exceptionally fast dual detectors, enabling researchers to screen millions of samples with the increased accuracy, speed and sensitivity. For walkaway convenience, the system can be equipped with a plate stacker for 20 or 50 plates or can also be fully automated and integrated for 24/7 workflow-driven automation. “We’re transforming drug discovery, and it all begins in the lab where researchers can leverage multimode plate reader technology like the EnVision Nexus system to increase R&D productivity at nearly every stage of their process,” said Alan Fletcher, PerkinElmer Senior Vice President of Life Sciences. “By focusing on workflow simplification and expanded assay capabilities in a state-of-the-art microplate reader, complemented by our optimized reagent technologies, our team has created an all-around high-performing system built for today and the future.”

The solution’s design draws on the company’s experience and success with its leading EnVision system, a workhorse in laboratories around the world for more than 20 years. Easy to setup, use and maintain, the new EnVision Nexus platform works across major detection technologies, including fluorescence intensity, fluorescence polarization, absorbance, luminescence and time-resolved fluorescence (TRF). This means a wide range of assays can be performed for different applications all with one instrument.

For more information, visit: www.perkinelmer.com

Digital issue: Please click here for more information